Cyclohexanols

Mar 27, 2020

Luye Pharma Continues to Deliver Strong Growth in 2019

Dec 26, 2019

Luye Pharma Submits New Drug Application in the U.S. for Its Antidepressant Drug LY03005

Oct 31, 2019

Syntrix Pharmaceuticals to Present Positive Desmetramadol Trial Results at the 2019 Pain Management SUMMIT

Aug 29, 2019

Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines

Jun 04, 2019

Syntrix Pharmaceuticals Announces Publication of Positive Double-Blind Clinical Trials Showing Desmetramadol Has the Analgesic and Side Effect Profile of Tramadol Without Its Metabolic Liabilities

Mar 20, 2019

Syntrix Announces First Patient Cohort Dosed in Phase 2 Study of Desmetramadol in Diabetic Neuropathic Pain

Dec 30, 2018

Luye Pharma Announces Innovative Drug - Risperidone Extended Release Microspheres for Injection has Reached Final Stage of NDA Process

Aug 29, 2018

Luye Pharma Releases its Financial Results for the First Half of 2018: Double-Digit Growth in Core Product Sales, Exceeded Expectations in Sales, R&D and M&As